EF-19, a post-approval registry study of tumor treating fields (TTFields) in recurrent glioblastoma (rGBM).

Zhu, JJ; O'Donnell, R; Ram, Z

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (15):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索